ReposiTrak 過去の業績
過去 基準チェック /36
ReposiTrakは、平均年間17%の収益成長を遂げていますが、 Software業界の収益は、年間 成長しています。収益は、平均年間22.5% 3.5%収益成長率で 成長しています。 ReposiTrakの自己資本利益率は14.4%であり、純利益率は30.1%です。
主要情報
17.05%
収益成長率
18.34%
EPS成長率
| Software 業界の成長 | 17.33% |
| 収益成長率 | 3.50% |
| 株主資本利益率 | 14.43% |
| ネット・マージン | 30.15% |
| 前回の決算情報 | 31 Mar 2026 |
最近の業績更新
Recent updates
ナラティブの更新 • May 05
TRAK: Expanding Food Traceability Adoption And Compliance Wins Will Drive Upside
Analysts have kept their ReposiTrak price target effectively unchanged at approximately $16.00, reflecting only very small tweaks in inputs such as discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their overall view of the stock. What's in the News A wholesale grocery cooperative in the Southern United States became the first wholesaler to reach full supplier to store traceability using ReposiTrak’s Touchless Traceability solution, achieving FSMA 204 compliance without case-level scanning or changes to distribution center workflows (Key Developments).ナラティブの更新 • Apr 19
TRAK: Expanding Traceability Network Adoption Will Support Future Upside
Analysts held ReposiTrak's fair value estimate at $16.00 per share while making only very small tweaks to assumptions such as the discount rate and future P/E, reflecting largely unchanged views on the stock's risk and earnings profile. What's in the News ReposiTrak reported that eighteen fresh fruit and vegetable companies have joined the queue for the ReposiTrak Traceability Network to prepare for FDA Key Data Element sharing across their supply chains, covering a wide range of growers and distributors across the United States (Key Developments).ナラティブの更新 • Apr 04
TRAK: Expanding Traceability Adoption And Share Repurchases Will Support Future Upside
Analysts have maintained their $16.00 price target on ReposiTrak, linking this steady view to only slight adjustments in discount rate and future P/E assumptions rather than any change in projected growth or profitability. What's in the News ReposiTrak and SPAR Group, Inc.ナラティブの更新 • Mar 21
TRAK: Expanding Traceability Adoption And Share Repurchases Will Support Future Upside
Analysts have reaffirmed a $16.00 price target for ReposiTrak, citing only minimal tweaks to underlying assumptions such as discount rate, revenue growth, profit margin and future P/E, which together leave their overall valuation view effectively unchanged. What's in the News A grocery retailer using ReposiTrak Touchless Traceability is reported as the first to achieve end to end traceability under FDA FSMA Section 204, with hundreds of thousands of Key Data Element records generated across shipments, and several more corporate customers nearing similar go live milestones (Key Developments).ナラティブの更新 • Mar 06
TRAK: Expanding Traceability Network And Share Buybacks Will Support Future Upside
Analysts have modestly reduced their price target on ReposiTrak to reflect a slightly lower future P/E assumption of 36.44x, while keeping key fair value and growth inputs broadly unchanged. What's in the News A grocery retailer using ReposiTrak Touchless Traceability has achieved end to end FSMA 204 traceability, generating hundreds of thousands of FDA Key Data Element records without case level scanning, with three more corporate customers close to similar go live points (Key Developments).ナラティブの更新 • Feb 19
TRAK: Traceability Network Adoption Will Support Higher Future Profitability
Analysts have reduced their price target on ReposiTrak from $29 to $16, citing updated assumptions in their models for slower revenue growth, a lower future P/E multiple, and a higher profit margin profile. What's in the News ReposiTrak reported completing a share repurchase program announced on May 9, 2019, buying back a total of 2,220,026 shares, or 11.63% of the company, for US$14.46 million, including 79,927 shares, or 0.44%, repurchased between October 1, 2025 and December 31, 2025 for US$1.1 million (Key Developments).Seeking Alpha • Jan 13
ReposiTrak: Better Business, Fairer Price, Still Not A Buy
Summary ReposiTrak, Inc. is a micro-cap SaaS firm focused on supply chain compliance, food safety, and traceability for retailers and suppliers. TRAK's revenue grew 10% YoY, driven by recurring subscriptions and expanding services to existing customers, especially as retailer requirements outpace federal mandates. Operating expenses rose 3%, but revenue outpaced costs, supporting a 28% increase in operating income and strong revenue-per-employee metrics. Liquidity remains robust with $28.8M in cash and zero debt, though higher tax rates and rising costs warrant close monitoring if adoption slows. Read the full article on Seeking Alpha分析記事 • Oct 01
Investors Will Want ReposiTrak's (NYSE:TRAK) Growth In ROCE To Persist
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...分析記事 • Aug 02
Subdued Growth No Barrier To ReposiTrak, Inc.'s (NYSE:TRAK) Price
ReposiTrak, Inc.'s ( NYSE:TRAK ) price-to-earnings (or "P/E") ratio of 46.4x might make it look like a strong sell...分析記事 • May 27
ReposiTrak's (NYSE:TRAK) Performance Is Even Better Than Its Earnings Suggest
ReposiTrak, Inc. ( NYSE:TRAK ) just reported healthy earnings but the stock price didn't move much. Investors are...分析記事 • Apr 12
Earnings Not Telling The Story For ReposiTrak, Inc. (NYSE:TRAK)
With a price-to-earnings (or "P/E") ratio of 62.3x ReposiTrak, Inc. ( NYSE:TRAK ) may be sending very bearish signals...分析記事 • Nov 09
ReposiTrak, Inc. (NYSE:TRAK) Not Lagging Market On Growth Or Pricing
With a price-to-earnings (or "P/E") ratio of 71.3x ReposiTrak, Inc. ( NYSE:TRAK ) may be sending very bearish signals...
新しいナラティブ • Oct 07
Critical Focus On Traceability Solutions Powers Revenue Growth And Profitability Surge
Emphasis on enhancing traceability solutions and strategic revenue focus predicts significant growth, with aims to improve net margins and year-over-year growth.Seeking Alpha • Oct 06
Track And Trace, But Don't Race: Why ReposiTrak Might Be Overvalued
Summary ReposiTrak shows solid growth potential with traceability services and recurring revenue but is currently overvalued with a high P/E ratio of 62.09x. Despite strong financials and profitability, rising operational expenses and heavy FDA dependency pose significant risks. Expansion into adjacent markets and AI-driven operational efficiencies are promising, but traceability revenue remains a small portion of the business. Given the speculative nature and high valuation, I recommend holding off on investing in ReposiTrak at this price. Read the full article on Seeking Alpha分析記事 • Jul 24
ReposiTrak, Inc.'s (NYSE:TRAK) P/E Is Still On The Mark Following 28% Share Price Bounce
ReposiTrak, Inc. ( NYSE:TRAK ) shareholders have had their patience rewarded with a 28% share price jump in the last...分析記事 • Mar 23
ReposiTrak (NYSE:TRAK) Has More To Do To Multiply In Value Going Forward
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...分析記事 • Feb 28
Why Investors Shouldn't Be Surprised By ReposiTrak, Inc.'s (NYSE:TRAK) 28% Share Price Surge
Despite an already strong run, ReposiTrak, Inc. ( NYSE:TRAK ) shares have been powering on, with a gain of 28% in the...収支内訳
収支内訳
ReposiTrak の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 26 | 23 | 7 | 12 | 0 |
| 31 Dec 25 | 24 | 7 | 12 | 0 |
| 30 Sep 25 | 23 | 7 | 12 | 0 |
| 30 Jun 25 | 23 | 7 | 11 | 0 |
| 31 Mar 25 | 22 | 6 | 11 | 0 |
| 31 Dec 24 | 21 | 6 | 11 | 0 |
| 30 Sep 24 | 21 | 6 | 11 | 0 |
| 30 Jun 24 | 20 | 5 | 11 | 0 |
| 31 Mar 24 | 20 | 5 | 11 | 0 |
| 31 Dec 23 | 20 | 5 | 10 | 0 |
| 30 Sep 23 | 19 | 5 | 10 | 0 |
| 30 Jun 23 | 19 | 5 | 10 | 0 |
| 31 Mar 23 | 19 | 5 | 10 | 0 |
| 31 Dec 22 | 19 | 4 | 10 | 0 |
| 30 Sep 22 | 18 | 4 | 10 | 0 |
| 30 Jun 22 | 18 | 3 | 10 | 0 |
| 31 Mar 22 | 18 | 3 | 10 | 0 |
| 31 Dec 21 | 20 | 3 | 10 | 0 |
| 30 Sep 21 | 20 | 4 | 10 | 0 |
| 30 Jun 21 | 21 | 4 | 10 | 0 |
| 31 Mar 21 | 22 | 3 | 10 | 0 |
| 31 Dec 20 | 21 | 2 | 10 | 0 |
| 30 Sep 20 | 20 | 1 | 10 | 0 |
| 30 Jun 20 | 20 | 1 | 11 | 0 |
| 31 Mar 20 | 19 | 1 | 11 | 0 |
| 31 Dec 19 | 19 | 2 | 10 | 0 |
| 30 Sep 19 | 20 | 3 | 10 | 0 |
| 30 Jun 19 | 21 | 3 | 11 | 0 |
| 31 Mar 19 | 23 | 4 | 11 | 0 |
| 31 Dec 18 | 23 | 4 | 11 | 0 |
| 30 Sep 18 | 23 | 3 | 12 | 0 |
| 30 Jun 18 | 22 | 3 | 11 | 0 |
| 31 Mar 18 | 21 | 2 | 11 | 0 |
| 31 Dec 17 | 20 | 3 | 10 | 0 |
| 30 Sep 17 | 19 | 3 | 10 | 0 |
| 30 Jun 17 | 19 | 3 | 9 | 0 |
| 31 Mar 17 | 18 | 3 | 9 | 0 |
| 31 Dec 16 | 16 | 2 | 8 | 0 |
| 30 Sep 16 | 15 | 1 | 9 | 0 |
| 30 Jun 16 | 14 | 0 | 9 | 0 |
| 31 Mar 16 | 14 | -3 | 9 | 0 |
| 31 Dec 15 | 13 | -6 | 10 | 0 |
| 30 Sep 15 | 13 | -7 | 10 | 0 |
| 30 Jun 15 | 14 | -7 | 10 | 0 |
質の高い収益: TRAKは 高品質の収益 を持っています。
利益率の向上: TRAKの現在の純利益率 (30.1%)は、昨年(28.8%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: TRAKの収益は過去 5 年間で年間17%増加しました。
成長の加速: TRAKの過去 1 年間の収益成長率 ( 11.5% ) は、5 年間の平均 ( 年間17%を下回っています。
収益対業界: TRAKの過去 1 年間の収益成長率 ( 11.5% ) Software業界11.7%を上回りませんでした。
株主資本利益率
高いROE: TRAKの 自己資本利益率 ( 14.4% ) は 低い とみなされます。
総資産利益率
使用総資本利益率
過去の好業績企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/27 07:48 |
| 終値 | 2026/05/27 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/06/30 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
ReposiTrak, Inc. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4
| アナリスト | 機関 |
|---|---|
| Thomas Forte | D.A. Davidson & Co. |
| Ananda Baruah | Loop Capital Markets |
| Thomas Forte | Maxim Group |